(Q43990782)

28 November 2017

title

Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia (English)

1 reference

28 November 2017

0 references

2

1 reference

28 November 2017

Elias K Angelopoulos

1

1 reference

28 November 2017

Eugenia G Daskalopoulou

series ordinal

3

1 reference

28 November 2017

John Hatzimanolis

series ordinal

4

1 reference

28 November 2017

John Tzemos

series ordinal

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

110

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

9-17

1 reference

Clomipramine enhances prolactin and growth hormone responses to L-tryptophan

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Decreased 5-HT-mediated prolactin release in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Serotonin, schizophrenia and antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

The effects of intravenous clomipramine on neurohormones in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Effects of antidepressant drugs on different receptors in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Differential prolactin responses to haloperidol and TRH in normal adult men

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Abnormal prolactin response to haloperidol challenge in men with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desimipramine in man in connection with chlorimipramine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Duration of psychosis and outcome in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Prolactin responses to haloperidol in drug-free and treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Increased brain dopamine and dopamine receptors in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

The dopamine hypothesis of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Monoamines and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Tritiated LSD Binding in Frontal Cortex in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900037-9

7 January 2021

10.1016/S0165-1781(02)00037-9

Identifiers

DOI

1 reference

28 November 2017

1 reference